Amyloid positron emission tomography (aPET) measurement of Alzheimer’s disease (AD) pathology could improve the accurate diagnosis of cognitive disorders.
Browsing: Neurodegenerative Disease Management
In this review, the authors discuss the history of DBS for Parkinson’s disease, as well as outcomes, recent advances, and where the field will go next.
In this review the authors explore an individualized approach to managing cognitive impairment in progressive supranuclear palsy.
Improving dementia care within primary care requires a transformation in care processes with an emphasis on interprofessional collaboration between family physicians, allied health professionals and specialists.
This study suggests that correct use of cognitive screening instruments may conveivably help to narrow the ‘dementia diagnosis gap’.
This study attempts to identify the published measurements of Huntington’s disease prevalence and reconcile the geographical variations in HD prevalence.
This article reviews the field of amyloid-beta immunotherapy for the treatment of Alzheimer’s disease.
This article puts forward the argument that neuropathology is not obsolete within dementia research, despite advances in neuroimaging and molecular biology techniques.
This article reviews currently available pain observation tools that utilize facial expressions, focusing in on efficacy in the assessment of pain in dementia patients.
Wayfinding skills deteriorate with cognitive impairment, making getting lost a significant risk for individuals with dementia. This article reviews the ‘Finding Your Way’ program designed to raise awareness of the issue and improve public and caregiver responses.